MRK

Merck & Company, Inc.

129.12 USD
+0.09 (+0.07%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Merck & Company, Inc. stock is up 6.46% since 30 days ago. The dividend yield is 2.58% and its next earnings date is Apr 25, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 42% of the previous 49 February’s closed higher than January. In the last 10 Unusual Options Trades, there were 7 CALLs, 3 PUTs. 84% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
27 Feb 14:52 21 Jun, 2024 135.00 CALL 191 1711
27 Feb 15:18 21 Jun, 2024 135.00 CALL 90 1711
27 Feb 15:22 21 Jun, 2024 135.00 CALL 312 1711
27 Feb 15:54 21 Jun, 2024 135.00 CALL 245 1711
27 Feb 16:42 19 Apr, 2024 125.00 CALL 55 11981
27 Feb 17:05 17 Jan, 2025 135.00 PUT 29 188
27 Feb 17:34 19 Jul, 2024 120.00 PUT 800 1221
27 Feb 19:26 17 May, 2024 125.00 CALL 80 1751
27 Feb 19:26 17 May, 2024 125.00 CALL 64 1751
27 Feb 19:38 19 Apr, 2024 130.00 PUT 116 269

About Merck & Company, Inc.

Merck & Co. operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services.

  • Cantor Fitzgerald
    Wed Feb 14, 11:31
    buy
    confirm
  • Cantor Fitzgerald
    Mon Feb 5, 11:17
    buy
    confirm
  • Truist Securities
    Fri Feb 2, 14:55
    buy
    confirm
  • UBS
    Fri Feb 2, 13:54
    buy
    confirm
  • Wells Fargo
    Fri Feb 2, 09:14
    hold
    confirm
  • Barclays
    Fri Feb 2, 08:20
    buy
    confirm